Miniaturized Vital Sign Monitoring for Newborns in the Delivery Room

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 24
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

This prospective observational study aims to evaluate the accuracy, safety, and feasibility of the Wireless MicroPremVitals Button Sensor System for continuous monitoring of electrocardiography (ECG), heart rate, respiratory rate, oxygen saturation, and skin temperature in newborn infants in the delivery room. Measurements obtained from the wireless sensor system will be compared with standard-of-care monitoring. The study will also assess skin tolerability, signal quality, and parent and healthcare provider perceptions of the device.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

Infants with skin abnormality would potentially increase the risk of injury.

Family experiencing too much stress as determined by an attending physician or bedside care team, to not be approached for recruitment.

Infants born at <35 weeks gestational age.

Trial population

Healthy newborn infants in the delivery room at the study site who are eligible for routine delivery room monitoring and whose parent(s) or legal guardian provide informed consent for study participation.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Wireless MicroPremVitals Button Sensor

    Device

    A wireless wearable sensor system applied to newborn infants in the delivery room to continuously measure electrocardiography (ECG), heart rate, respiratory rate, oxygen saturation, and skin temperature. Measurements will be compared with standard-of-care monitoring for validation purposes only and will not be used for clinical decision-making.

Treatment groups

5 Participants
are divided into 1 treatment group
Group A: Newborn Infants1 intervention

Trial outcomes

Primary outcomes

1

Electrocardiography (ECG) Accuracy

Agreement between ECG measurements obtained using the Wireless MicroPremVitals Button Sensor System and the standard-of-care Dräger Infinity M540 monitor.

Time frame
During two 15-minute monitoring periods within the first 90 minutes after birth
2

Skin Temperature Accuracy

Agreement between skin temperature measurements obtained using the Wireless MicroPremVitals Button Sensor System and the standard-of-care Dräger Infinity M540 monitor.

Time frame
During two 15-minute monitoring periods within the first 90 minutes after birth.
3

Oxygen Saturation (SpO₂) Accuracy

Agreement between oxygen saturation (SpO₂) measurements obtained using the Wireless MicroPremVitals Button Sensor System and the standard-of-care Dräger Infinity M540 monitor.

Time frame
During two 15-minute monitoring periods within the first 90 minutes after birth.

Secondary outcomes

1

Heart Rate Accuracy

Heart rate will be calculated offline from raw optical and motion data collected by the Wireless MicroPremVitals Button Sensor System. Agreement between calculated heart rate and the standard-of-care Dräger Infinity M540 monitor will be evaluated.

Time frame
During two 15-minute monitoring periods within the first 90 minutes after birth.
2

Heart Rate Variability (HRV)

Heart rate variability will be calculated offline from raw optical and motion data collected by the Wireless MicroPremVitals Button Sensor System. Derived HRV measurements will be compared with HRV derived from the standard-of-care Dräger Infinity M540 monitor.

Time frame
During two 15-minute monitoring periods within the first 90 minutes after birth.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: